{
  "id": 57076,
  "title": "AstraZeneca, Bristol Myers are in talks about merger — report",
  "url": "https://urgent.news/2026/08/02/astrazeneca-bristol-myers-are-in-talks-about-merger-report",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-02T20:27:37.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/astrazeneca-bristol-myers-are-in-talks-about-merger-report/"
  },
  "original_language": "en",
  "account": null,
  "summary": "AstraZeneca and Bristol Myers Squibb are in talks about a potential merger. According to the Financial Times, a deal would create one of the largest pharmaceutical companies in the world. The combined value of the two companies is around $400 billion.\n\nAstraZeneca, valued at around $264 billion, and Bristol Myers Squibb, valued at around $133 billion, have been discussing a merger in recent months. If completed, the deal would be one of the largest in industry history.\n\nThe merger would further AstraZeneca's focus on the US market, according to Handelsblatt. AstraZeneca's CEO Pascal Soriot has been pursuing this strategy, including upgrading the company's listing in New York in June.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "Handelsblatt",
        "title": "Pharma: AstraZeneca apparently considering mega-merger with US rival Bristol Myers Squibb",
        "url": "https://urgent.news/2026/08/02/pharma-astrazeneca-erwagt-offenbar-mega-fusion-mit-us-rivalen-bristol",
        "published": "2026-08-02T19:26:43.000Z"
      },
      {
        "outlet": "Financial Times",
        "title": "AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough",
        "url": "https://urgent.news/2026/08/03/astrazeneca-and-bristol-myers-when-big-pharma-isnt-big-enough",
        "published": "2026-08-03T16:33:17.000Z"
      },
      {
        "outlet": "Endpoints News",
        "title": "Biopharma industry questions potential AstraZeneca, Bristol Myers merger",
        "url": "https://urgent.news/2026/08/03/biopharma-industry-questions-potential-astrazeneca-bristol-myers",
        "published": "2026-08-03T19:20:35.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}